HERMES Arzneimittel Holding
↗Pullach im Isartal, Germany
HERMES Arzneimittel Holding is a leading German pharmaceutical group founded in 1907 that develops, manufactures, and markets self-medication products including vitamins, calcium tablets, joint treatments, cough medicines, and over-the-counter pharmaceuticals. Operating under the umbrella of the Johannes Burges Family Foundation since 2019, the holding comprises three main operating companies: HERMES ARZNEIMITTEL (OTC self-medication), HERMES PHARMA (contract manufacturer and CDMO for user-friendly dosage forms), and Bad Heilbrunner (herbal teas and natural remedies). The group has established itself as one of Germany's leading exclusive partners for pharmacies, with a 117-year legacy focused on high-quality standards in pharmaceutical development, manufacturing, and distribution.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:Over-the-counter (OTC) medications, Contract Manufacturing (CDMO)
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$250M - $750M
Founded:1907
Ownership:private
Status:operating
FUNDING
Investors:Johannes Burges Family Foundation
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Herbal/botanical, Dietary supplements, Topical formulations, Effervescent tablets, Chewable tablets, Lozenges, Orally disintegrating granules
Trial Phases:-
CORPORATE STRUCTURE
Subsidiaries:HERMES ARZNEIMITTEL GmbH, HERMES PHARMA GmbH, Bad Heilbrunner Naturheilmittel GmbH & Co. KG
Key Partnerships:Omega Pharma (distribution cooperation, announced 2025), iNova Pharmaceuticals (brand acquisition - Betaisodona®), Krewel Meuselbach (brand acquisition - Aspecton®, Ginkgo-Maren®)
COMPETITION
Position:Niche Player
Competitors:Reckitt Benckiser (OTC), Johnson & Johnson (OTC division), GSK Consumer Healthcare, Sanofi (OTC products), Boehringer Ingelheim (OTC)
LEADERSHIP
Key Executives:
Thomas Stadler - Co-Head/Business Manager
Tobias Brodtkorb - Co-Head/Business Manager
Dr. Jürgen Ott - CEO, HERMES PHARMA
Marinus Leeflang - Head of Drug Regulatory Affairs, HERMES PHARMA
Holger Dietel - Representative (Impressum)
Jörg Wieczorek - Representative (Impressum)
Scientific Founders:Franz Gradinger (founder, 1907)
LINKS
Website:hermes-holding.group
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of HERMES Arzneimittel Holding and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with HERMES Arzneimittel Holding. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.